Search

Displaying results 3931 - 3940 of 5451 in total
  1. Drug

    ODN M362

    go.drugbank.com/drugs/DB16485
    Experimental

  2. Drug

    Pexelizumab

    go.drugbank.com/drugs/DB04949
    Investigational

    It is being investigated by Alexion Pharmaceuticals.

  3. Drug

    ZK-93423

    go.drugbank.com/drugs/DB17063
    Experimental

    ZK-93423 is a beta-carboline with muscle relaxant activity with agonistic properties at the benzodiazepine receptor.[A253172]

  4. Drug

    Ocaratuzumab

    go.drugbank.com/drugs/DB17359
    Investigational

    It is being investigated for cancers and autoimmune disorders.

  5. Drug

    Allopurinol riboside

    go.drugbank.com/drugs/DB17738
    Experimental

    Allopurinol riboside is a nucleoside analogue of [allopurinol] with a beta-D-ribofuranosyl moiety at the 1-position.

  6. Drug

    Sulopenem

    go.drugbank.com/drugs/DB15284
    Investigational

    It is marketed as the prodrug [sulopenem etzadroxil] in combination with [probenecid].[L51768]

  7. Drug

    β-Methylfentanyl

    go.drugbank.com/drugs/DB09171
    ExperimentalIllicit

    It is an analog of the potent opioid, fentanyl.

  8. Drug

    Inositol 1,3-bisphosphate

    go.drugbank.com/drugs/DB02942
    Experimental

    It is an experimental compound with no approved therapeutic indications. … It has molecular formula C6H14O12P2 and is categorized as a sugar phosphate/sugar alcohol.

  9. Drug

    Desmethylprodine

    go.drugbank.com/drugs/DB01478
    ExperimentalIllicit

    It has been listed as a Schedule I controlled drug in the United States, and thus is not used clinically. It is known to be a designer drug, synthesized in 1977, for the purpose of recreational use.

  10. Drug

    Aptazapine

    go.drugbank.com/drugs/DB09305
    Experimental

    Although Aptazapine reached clinical trials, it was never marketed. … It antagonised α2 adrenergic receptors approximately 10 times more effectively than mianserin, antagonised 5-HT2 receptors, agonised H1 receptors, and did not affect reuptake of serotonin or norepinephrine